Gilead Sciences CDR (CAD Hedged) (GILD)

Gilead Sciences CDR (CAD Hedged) (GILD $29.18)
- $29.18 P/E (TTM): 373.55X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $496.73)
- $496.73 P/E (TTM): 66.61X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $472.01)
- $472.01 P/E (TTM): 32.86X Cap: $119.22B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $225.64)
- $225.64 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $230.75)
- $230.75 P/E (TTM): 21.94X Cap: $555.94B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,044.13)
- $1,044.13 P/E (TTM): 50.74X Cap: $987.10B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $113.37)
- $113.37 P/E (TTM): 14.58X Cap: $281.38B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $174.14)
- $174.14 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $639.60)
- $639.60 P/E (TTM): 53.17X Cap: $53.53B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $74.45)
- $74.45 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $102.67)
- $102.67 P/E (TTM): 17.11X Cap: $19.64B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.00)
- $25.00 P/E (TTM): 14.13X Cap: $3.07B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $29.18)
- $29.18 P/E (TTM): 373.55X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026